Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Review Artilce Volume 3 Issue 3

Tuberculosis in the Central Nervous System

Guerrero-De León JE1 and Rodríguez-Leyva I1,2*

1School of Medicine, Universidad Autónoma De San Luis Potosí
2Neurology Department, Hospital Central “Dr. Ignacio Morones Prieto”. San Luis Potosí, S.L.P., México

*Corresponding Author: Rodríguez-Leyva I, School of Medicine, Universidad Autónoma De San Luis Potosí and Neurology Department, Hospital Central “Dr. Ignacio Morones Prieto”. San Luis Potosí, S.L.P., México.

Received: January 03, 2020; Published: February 08, 2020


  Tuberculosis (TB) is an ancient, reemerging, infectious, chronic and highly fatal disease. It is caused by bacilli of the genus Mycobacterium and is considered as a complex of microbiological and immunological phenomena that represents a significant public health issue in Mexico and in the world [1]. According to the World Health Organization, it is estimated that a quarter of the world’s population has latent TB, that is, they are infected by the bacilli, but have not yet become ill or can not spread the infection [2]. These individuals have a 5 -15% risk of developing the illness throughout their lives, and two million will die because of this disease [3].



  1. World Health Organization. Global tuberculosis report (2019). 
  2. World Health Organization. Tuberculosis fact sheet (2018).
  3. Kurt T. Tuberculosis, detección de casos, tratamiento y vigilancia. Organización Panamericana de la Salud. Segunda edición. Washington, D.C (2004).
  4. Riley LW. Tuberculosis: Natural history, microbiology, and pathogenesis (2019).
  5. McNeil MR and Brennan PJ. “Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance some thoughts and possibilities arising from recent structural information”. Research in Microbiology 142.4 (1991): 451.
  6. Allen BW and Mitchison DA. “Counts of viable tubercle bacilli in sputum related to smear and culture gradings”. Medical Laboratory Scientist 49.2 (1992): 94. 
  7. Centro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE). Programa preventivo de dirección de micobacteriosis. 
  8. Rom WN and Garay SM. “Tuberculosis”. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins (2004).
  9. Ryan KJ. “Sherris Medical Microbiology”. 7th Edition. United States: McGraw-Hill Education (2018).
  10. Shafer RW. “Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection”. Medicine (Baltimore) 70.6 (1991): 384-397. 
  11. Zumla A., et al. “Impact of HIV infection on tuberculosis”. Postgraduate Medical Journal 76 (2000): 259-268.
  12. Rock RB., et al. “Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects”. Clinical Microbiology Reviews 21.2 (2008): 243-261.
  13. Dastur DK., et al. “Pathology and pathogenetic mechanisms in neurotuberculosis”. Radiologic Clinics of North America 33.4 (1995): 733. 
  14. Rock RB., et al. “Role of microglia in central nervous system infections”. Clinical Microbiology Reviews 17.4 (2004): 942-964.
  15. Rich AR and Mc Cordock HA. “The pathogenesis of tuberculous meningitis”. Bulletin of the Johns Hopkins Hospital 52 (1933): 5-37.
  16. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2013. US Department of Health and Human Services, Atlanta, GA (2014).
  17. Navarro-Cano G., et al. “Tuberculosis (TB) del sistema nervioso central (SNC). Experiencia de 3 años en su diagnóstico y tratamiento en el Hospital Central Dr. Ignacio Morones Prieto de San Luis Potosí, S.L.P”. Revista Mexicana de Neurociencia 1.3 (2000): 12-18. 
  18. Leonard JM. “Central nervous system tuberculosis”. Bernardo J, Edwards MS (2019).
  19. Kennedy DH and Fallon RJ. “Tuberculous meningitis”. Journal of the American Medical Association. 241.3 (1979): 264. 
  20. Kumar R., et al. “Tuberculous brain abscess: clinical presentation, pathophysiology and treatment (in children)”. Child's Nervous System 18 (2002): 118-123. 
  21. Vaziri S., et al. “Tuberculous ventriculitis: A rare complication of central nervous system tuberculosis”. International Journal of Mycobacteriology 5 (2016): 231-234.
  22. Pepper DJ., et al. “Neurologic Manifestations of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome: A Case Series”. Clinical Infectious Diseases 48.11 (2009): e96-e107.
  23. Chakraborti S., et al. “Clinicopathological study of tuberculous brain abscess”. Pathology - Research and Practice 205 (2009): 815-822.
  24. Dastur DK., et al. “The brain and meninges in tuberculous meningitis. Gross pathology in 100 cases and pathogenesis”. Neurology 18 (1970): 86-100.
  25. Javaud N., et al. “Tuberculous cerebral vasculitis: retrospective study of 10 cases”. European Journal of Internal Medicine 22.6 (2011): e99-104.
  26. Sharon-Tai ML., et al. “Cerebral infarction pattern in tuberculous meningitis”. NATURE Scientific Reports 6.38802 (2016): 1-10. 
  27. Konar SK., et al. “Tuberculous lumbar arachnoiditis mimicking conus cauda tumor: A case report and review of literature”. Journal of Neurosciences in Rural Practices 2.1 (2011): 93-96.
  28. Hoffman GS. “Spinal arachnoiditis: What is the clinical spectrum?”. Spine 8 (1983): 538-540. 
  29. Arias-Deroncerés IJ., et al. “Tuberculosis vertebral (mal de Pott) e infección por el virus de la inmunodeficiencia humana”. Medisan 15.12 (2011): 1791-1797. 
  30. Kumar Garg R and Singh Somvanshi DS. “Spinal tuberculosis: A review”. The Journal of Spinal Cord Medicine 34.5 (2011): 440-454. 
  31. Schaller MA., et al. “Central Nervous System Tuberculosis: Etiology, Clinical Manifestations and Neuroradiological Features”. Clinical Neuroradiology 29.1 (2019): 3-18.
  32. Garcia-Monco JC. “Tuberculosis”. In: Biller J, Ferro J, editors. Handb Clin Neurol. Neurol Asp Syst Dis Part III. 3rd Series 121. Amsterdam: Elsevier (2014). 
  33. Thwaites G., et al. “British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children”. Journal of Infection 59 (2009): 167-187. 
  34. Jeren T and Beus I. “Characteristics of cerebrospinal fluid in tuberculous meningitis”. Acta Cytologica 26 (1982): 678-680. 
  35. Bernaerts A., et al. “Tuberculosis of the central nervous system: overview of neuroradiological findings”. European Radiology 13 (2003): 1876-1890. 
  36. Botha H., et al. “Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis”. PLoS One 7 (2012): e38982.
  37. WHO. Meeting Report of a Technical Expert Consultation: Non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF (2017).
  38. Woodfield J and Argent A. “Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-microbial treatment for tuberculous meningitis?”. Journal of Tropical Pediatrics 54.4 (2008): 220-224. 
  39. Jullien S., et al. “Six months therapy for tuberculous meningitis (Review)”. Cochrane Database of Systematic Reviews 9 (2016): 012091.
  40. Heemskerk D., et al. “Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial”. Trials 12 (2011): 25. 
  41. Nahid P., et al. “Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of American clinical practice guidelines: Treatment of drug-susceptible tuberculosis”. Clinical Infectious Diseases 63 (2016): e147.
  42. Para la prevención y control de la tuberculosis. Norma Oficial Mexicana NOM-006-SSA2-2013. Diario Oficial de la federación (2013).
  43. Donald PR. “Cerebrospinal fluid concentrations of antituberculosis agents in adults and children”. Tuberculosis 90.5 (2010): 279.
  44. Thwaites GE., et al. “Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults”. The New England Journal of Medicine 351.17 (2004): 1741. 
  45. American Academy of Pediatrics. Red Book:Report of the Committee on Infectious Diseases, 31st ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL (2018).


Citation: Guerrero-De León JE and Rodríguez-Leyva I. Tuberculosis in the Central Nervous System". Acta Scientific Microbiology 3.3 (2020): 01-07.

Member In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US